Xeris Pharmaceuticals
XERS
10.11
+0.04
+0.40%
Xeris Pharmaceuticals
US · XERS
#2862 by market cap
Listed 2018
10.11
+0.04
+0.40%
Live - 5344 symbols - heartbeat 488s ago
· 2026-10-08 06:44
Pre-market
10.00
-1.09%
After-hours
10.00
-1.09%
- Market cap
- 1.84B
- P/E (TTM)i
- -104.23
- P/Bi
- -190.75
- EPSi
- 0.00
- Div yieldi
- 0.00%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on XERS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 4.3 percentage points.
Institutional ownership
- Held by institutions
- 60.85% -4.29pp
- Institutions
- 281 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund39.06%
Hedge Fund14.63%
Public Company3.64%
Individual/Insider3.44%
Insurance Company1.11%
Government Pension Fund0.81%
Private Company0.80%
Sovereign Wealth Fund0.44%
VC/PE Fund0.26%
Other35.80%
Top holders as of 2026-06-30
BlackRock
7.97% · 14.53M sh
Vanguard Capital Management, LLC
4.70% · 8.56M sh
D. E. Shaw & Co., L.P.
4.28% · 7.80M sh
State Street Global Advisors
2.64% · 4.82M sh
Geode Capital Management, LLC
2.59% · 4.72M sh
Teachers Insurance and Annuity Association-College Retirement Equities Fund
2.33% · 4.25M sh
Rosalind Advisors, Inc.
1.60% · 2.91M sh
Qube Research & Technologies Ltd
1.59% · 2.89M sh
Vanguard Portfolio Management, LLC
1.44% · 2.63M sh
Wellington Management Group
1.30% · 2.37M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 18 buys · 32 sells
| Name | Role | Stake |
|---|---|---|
| Kevin McCulloch | Chief Commercial Officer | 0.89% |
| John Shannon | President | 0.85% |
| Steven Pieper | Chief Financial Officer | 0.51% |
| John Johnson | Independent Non-Executive Director | 0.37% |
| Beth Hecht | Chief Legal Officer | 0.35% |
| Garheng Albert Kong | Independent Non-Executive Director | 0.12% |
| Jeffrey Sherman | Independent Director | 0.10% |
| Marla Persky | Independent Director | 0.07% |
| Barbar-Jean Bormann-Kennedy | Independent Director | 0.07% |
| Dawn Halkuff | Independent Director | 0.06% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Beth Hecht | Chief Legal Officer | Automatic Disposition | -16,666 | $9.41 |
| 2026-09-30 | Kevin McCulloch | Chief Commercial Officer | Automatic Disposition | -15,000 | $9.41 |
| 2026-09-30 | Steven Pieper | Chief Financial Officer | Automatic Disposition | -5,000 | $9.41 |
| 2026-09-27 | Kevin McCulloch | Chief Commercial Officer | Automatic Disposition | -25,000 | $10.00 |
| 2026-08-31 | Beth Hecht | Chief Legal Officer | Automatic Disposition | -16,666 | $8.49 |
| 2026-08-31 | Kevin McCulloch | Chief Commercial Officer | Automatic Disposition | -15,000 | $8.49 |
| 2026-08-31 | Steven Pieper | Chief Financial Officer | Automatic Disposition | -5,000 | $8.50 |
| 2026-08-11 | Steven Pieper | Chief Financial Officer | Automatic Disposition | -5,000 | $8.50 |
| 2026-08-02 | Beth Hecht | Chief Legal Officer | Automatic Disposition | -16,666 | $8.01 |
| 2026-08-02 | Kevin McCulloch | Chief Commercial Officer | Automatic Disposition | -15,000 | $8.02 |
| 2026-07-31 | John Shannon | President | Sale to Issuer | -36,645 | $8.08 |
| 2026-07-31 | Kevin McCulloch | Chief Commercial Officer | Sale to Issuer | -21,918 | $8.08 |
| 2026-07-06 | Steven Pieper | Chief Financial Officer | Automatic Disposition | -45,000 | $8.50–8.52 |
| 2026-07-06 | Steven Pieper | Chief Financial Officer | Intent to Sell (Form 144) | -27,600 | $8.37 |
| 2026-07-05 | Steven Pieper | Chief Financial Officer | Intent to Sell (Form 144) | -17,400 | $8.28 |
| 2026-06-30 | Beth Hecht | Chief Legal Officer | Automatic Disposition | -16,666 | $8.03 |
| 2026-06-30 | Nerissa Kreher | Director | Other Acquisition | +33,582 | -- |
| 2026-06-30 | Nerissa Kreher | Director | Other Derivative Acquisition | +37,910 | $8.00 |
| 2026-06-30 | Kevin McCulloch | Chief Commercial Officer | Automatic Disposition | -90,000 | $8.03 |
| 2026-06-03 | Garheng Albert Kong | Independent Non-Executive Director | Other Acquisition | +24,193 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:44:43 · For reference only, not investment advice and not tailored to your situation.